CM
CM Management Portfolio holdings
AUM
$110M
This Quarter Return
+5.23%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$110M
AUM Growth
+$110M
(+10%)
Cap. Flow
-$12.5M
Cap. Flow
% of AUM
-11.42%
Top 10 Holdings %
Top 10 Hldgs %
39.83%
Holding
76
New
22
Increased
18
Reduced
15
Closed
9
Top Buys
| 1 |
MarineMax
HZO
|
$2.01M |
| 2 |
IQVIA
IQV
|
$1.89M |
| 3 |
Winnebago Industries
WGO
|
$1.16M |
| 4 |
Warner Bros
WBD
|
$1.15M |
| 5 |
Pfizer
PFE
|
$1.09M |
Top Sells
| 1 |
Nektar Therapeutics
NKTR
|
$19.5M |
| 2 |
Freeport-McMoran
FCX
|
$2.65M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$2.48M |
| 4 |
Cytokinetics
CYTK
|
$1.61M |
| 5 |
Cohu
COHU
|
$1.54M |
Sector Composition
| 1 | Healthcare | 31.09% |
| 2 | Technology | 10.92% |
| 3 | Materials | 10.24% |
| 4 | Financials | 10.01% |
| 5 | Industrials | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alico
ALCO
$259M
| $7.35M | 6.7% | 225,000 | – | – |
|
|
TGB
2
Taseko Mines
TGB
$1.03B
| $7.25M | 6.6% | 2,300,000 -150,000 | -6% | -$473K |
|
3
Rigel Pharmaceuticals
RIGL
$697M
| $4.68M | 4.26% | 250,000 | – | – |
|
4
Radiant Logistics
RLGT
$305M
| $4.56M | 4.15% | 750,000 -25,000 | -3% | -$152K |
|
5
Preformed Line Products
PLPC
$941M
| $4.47M | 4.08% | 28,000 | – | – |
|
6
BGC Group
BGC
$4.65B
| $3.58M | 3.26% | 350,000 +50,000 | +17% | +$512K |
|
7
Newmark Group
NMRK
$3.22B
| $3.34M | 3.04% | 275,000 | – | – |
|
8
inTEST
INTT
$87.3M
| $3.06M | 2.79% | 420,594 +45,594 | +12% | +$332K |
|
|
9
Warner Bros
WBD
$28.8B
| $2.87M | 2.61% | 250,000 +100,000 | +67% | +$1.15M |
|
10
Amicus Therapeutics
FOLD
$2.34B
| $2.58M | 2.35% | 450,000 | – | – |
|
11
Talos Energy
TALO
$1.73B
| $2.54M | 2.32% | 300,000 -50,000 | -14% | -$424K |
|
12
Sabre
SABR
$706M
| $2.53M | 2.3% | 800,000 +100,000 | +14% | +$316K |
|
13
ClearPoint Neuro
CLPT
$298M
| $2.39M | 2.17% | 200,000 +25,000 | +14% | +$299K |
|
14
Republic Bancorp
RBCAA
$1.5B
| $2.34M | 2.13% | 32,000 -3,000 | -9% | -$219K |
|
15
ARKO Corp
ARKO
$564M
| $2.33M | 2.12% | 700,000 -350,000 | -33% | -$1.16M |
|
16
Park Hotels & Resorts
PK
$2.35B
| $2.3M | 2.1% | 225,000 +25,000 | +13% | +$256K |
|
17
Viatris
VTRS
$12.3B
| $2.23M | 2.03% | 250,000 +25,000 | +11% | +$223K |
|
18
Organon & Co
OGN
$2.45B
| $2.18M | 1.98% | 225,000 +75,000 | +50% | +$726K |
|
|
19
MarineMax
HZO
$566M
| $2.01M | 1.83% | +80,000 | New | +$2.01M |
|
|
CGAU
20
Centerra Gold
CGAU
$1.66B
| $1.98M | 1.81% | 275,000 -75,000 | -21% | -$541K |
|
21
Brookline Bancorp
BRKL
$976M
| $1.9M | 1.73% | 180,000 | – | – |
|
|
22
IQVIA
IQV
$32.4B
| $1.89M | 1.72% | +12,000 | New | +$1.89M |
|
23
Ark Restaurants
ARKR
$24.6M
| $1.8M | 1.64% | 200,000 | – | – |
|
24
Atea Pharmaceuticals
AVIR
$267M
| $1.8M | 1.64% | 500,000 | – | – |
|
25
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $1.65M | 1.5% | 2,250,000 +102,500 | +5% | +$75K |
|